The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of serum thymidine kinase-1 (TK1) activity in patients (pts) with hormone receptor positive (HR+) advanced breast cancer (ABC) treated with endocrine therapy (ET) in the EFECT trial.
 
Luca Malorni
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Pfizer
Travel, Accommodations, Expenses - Janssen; Roche
 
Chiara Biagioni
No Relationships to Disclose
 
Amelia McCartney
No Relationships to Disclose
 
Gaia Schiavon
Employment - AstraZeneca
 
Mattias Bergqvist
Employment - Biovica
Stock and Other Ownership Interests - Biovica
Honoraria - Biovica
Travel, Accommodations, Expenses - Biovica
 
Matteo Benelli
No Relationships to Disclose
 
Ilenia Migliaccio
Honoraria - AstraZeneca (I); Pfizer (I)
Consulting or Advisory Role - Novartis (I); Pfizer (I)
Research Funding - Pfizer (I)
Travel, Accommodations, Expenses - Janssen (I); Roche (I)
 
Laura Biganzoli
Honoraria - AstraZeneca; Celgene; Pfizer; Pierre Fabre; Takeda
Consulting or Advisory Role - AstraZeneca; Celgene; Eisai; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Celgene
Travel, Accommodations, Expenses - Ipsen
 
Martina Bonechi
No Relationships to Disclose
 
Giulia Boccalini
No Relationships to Disclose
 
Marta Pestrin
No Relationships to Disclose
 
Francesca Galardi
No Relationships to Disclose
 
Francesca De Luca
No Relationships to Disclose
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Periphagen; Pfizer; PharmaMar; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Radius Health
 
William John Gradishar
Consulting or Advisory Role - Abbvie; Celldex; Genentech/Roche; Genomic Health
 
Stephen K. L. Chia
Honoraria - Genomic Health; Novartis
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genomic Health (Inst); Novartis (Inst); Roche (Inst)
 
Angelo Di Leo
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Genomic Health; Lilly; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Ipsen; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche
Research Funding - AstraZeneca; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Celgene; Daiichi Sankyo; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche